Recently, President Trump issued four executive orders related to prescription drug prices. The first three orders were effective on July 24, 2020. The fourth executive order, which concerns drug prices for Medicare Part B drugs, has a delayed effective date. It calls for a change in the purchase price of those Part B drugs under what the President called a most favored nation status (MFN) provision. A MFN is a contract provision that assures the buyer that they are getting the lowest price that the seller has agreed to with other buyers. As with all things health insurance, it’s a bit more complicated than it appears.
|